<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<database>
    <trialList>
        <attritionBiasJudgement>“One patient dropped out after 2 weeks due to non-compliance” “Two patients developed significant medical illnesses ... unrelated to study treatment”, “By prior design, treatment for the first 8 patients was terminated after 8 weeks.”.</attritionBiasJudgement>
        <attritionBiasRisk>Low risk</attritionBiasRisk>
        <authorYearLetter>Adler1993</authorYearLetter>
        <countries>USA</countries>
        <crgID>0</crgID>
        <crossoverTrial>false</crossoverTrial>
        <designAddedInfo></designAddedInfo>
        <designProse>Design: parallel group</designProse>
        <detectionBiasJudgement>"Both rater and patient were blind to the patient's drug assignment". No further details.</detectionBiasJudgement>
        <detectionBiasRisk>Unclear Risk</detectionBiasRisk>
        <dobj>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>7</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>22</group1Total>
            <group2Events>5</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>15</group2Total>
            <outcomeName>Leaving study early</outcomeName>
            <subgroupName>long-term</subgroupName>
        </dobj>
        <factorialTrial>false</factorialTrial>
        <mainAuthor>Adler</mainAuthor>
        <meerKatCountry>USA</meerKatCountry>
        <nrControl>0</nrControl>
        <nrIntervention>0</nrIntervention>
        <nrOfParticipants>0</nrOfParticipants>
        <otherBiasJudgement>Baseline AIMS scores were somewhat higher in the vitamin E group than in the placebo group, however, this difference was not statistically significant. Small sample size.</otherBiasJudgement>
        <otherBiasRisk>Unclear Risk</otherBiasRisk>
        <otherDesign>false</otherDesign>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>20</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>22</group1Total>
            <group2Events>14</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>15</group2Total>
            <outcomeName>Tardive dyskinesia: 1. Not improved to a clinically important extent</outcomeName>
            <subgroupName>medium-term</subgroupName>
        </outcomeList>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>7</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>22</group1Total>
            <group2Events>9</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>15</group2Total>
            <outcomeName>Tardive dyskinesia: 2. Not any improvement</outcomeName>
            <subgroupName>medium-term</subgroupName>
        </outcomeList>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>1</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>16</group1Total>
            <group2Events>5</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>12</group2Total>
            <outcomeName>Tardive dyskinesia: 4. Deterioration of symptoms</outcomeName>
            <subgroupName>medium-term</subgroupName>
        </outcomeList>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>1</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>22</group1Total>
            <group2Events>0</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>15</group2Total>
            <outcomeName>Any adverse effect</outcomeName>
            <subgroupName>medium-term</subgroupName>
        </outcomeList>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>7</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>22</group1Total>
            <group2Events>4</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>15</group2Total>
            <outcomeName>Leaving study early</outcomeName>
            <subgroupName>medium-term</subgroupName>
        </outcomeList>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>7</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>22</group1Total>
            <group2Events>5</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>15</group2Total>
            <outcomeName>Leaving study early</outcomeName>
            <subgroupName>long-term</subgroupName>
        </outcomeList>
        <paralellTrial>true</paralellTrial>
        <performanceBiasJudgement>"Both rater and patient were blind to the patient's drug assignment". No further details.</performanceBiasJudgement>
        <performanceBiasRisk>Unclear Risk</performanceBiasRisk>
        <references>JOURNAL_ARTICLE</references>
        <references>YES</references>
        <references>Adler LA, Edson R, Lavori P, Peselow E, Duncan E, Rosenthal M, et al</references>
        <references>Long-term treatment effects of vitamin E for tardive dyskinesia</references>
        <references>Biological Psychiatry</references>
        <references>1998</references>
        <references>43</references>
        <references></references>
        <references>868-72</references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references>CONFERENCE_PROC</references>
        <references>NO</references>
        <references>Adler LA, Peselow E, Angrist B, Duncan E, Lee M, Rosenthal M, et al</references>
        <references>Vitamin E in tardive dyskinesia: effects of longer term treatment</references>
        <references>Proceedings of the 31st Annual Meeting of the American College of Neuropsychopharmacology; 1992 Dec 14-18; San Juan, Puerto Rico</references>
        <references>1992</references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references>JOURNAL_ARTICLE</references>
        <references>NO</references>
        <references>Adler LA, Peselow E, Duncan E, Rosenthal M, Angrist B</references>
        <references>Vitamin E in tardive dyskinesia: time course of effect after placebo substitution</references>
        <references>Psychopharmacology Bulletin</references>
        <references>1993</references>
        <references>29</references>
        <references></references>
        <references>371-4</references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references>JOURNAL_ARTICLE</references>
        <references>NO</references>
        <references>Adler LA, Peselow E, Rotrosen J, Duncan E, Lee M, Rosenthal M, et al</references>
        <references>Vitamin E treatment of tardive dyskinesia</references>
        <references>American Journal of Psychiatry</references>
        <references>1993</references>
        <references>150</references>
        <references>9</references>
        <references>1405-7</references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <reportingBiasJudgement>All expected outcomes have been reported but there is no study protocol to confirm that all planned outcomes were reported.</reportingBiasJudgement>
        <reportingBiasRisk>Unclear Risk</reportingBiasRisk>
        <revManID>STD-Adler-1993</revManID>
        <selectionBiasAllocationConcealmentBiasRisk>Unclear Risk</selectionBiasAllocationConcealmentBiasRisk>
        <selectionBiasAllocationConcealmentJudgement>"We used a randomization of 3:2 (vitamin E to placebo) to maximize the number of patients receiving active treatment while maintaining the blind". No further details.</selectionBiasAllocationConcealmentJudgement>
        <selectionBiasRandomSequenceBiasRisk>Unclear Risk</selectionBiasRandomSequenceBiasRisk>
        <selectionBiasRandomSequenceJudgement>"Patients were randomly assigned to treatment with Vitamin E, 400IU, or one matching placebo capsule, by mouth, b.i.d." No further details.</selectionBiasRandomSequenceJudgement>
        <year>1993</year>
    </trialList>
    <trialList>
        <attritionBiasJudgement>“Of the 51 subjects who did not complete 1 year, most changed their minds about participating (n=18), moved too far away from a site to continue in the study (n=11), or were classified as “whereabouts unknown” (n=8)”. “Per protocol, we analyzed the data according to the intention- to-treat principle.”.</attritionBiasJudgement>
        <attritionBiasRisk>Low risk</attritionBiasRisk>
        <authorYearLetter>Adler1999</authorYearLetter>
        <countries>USA</countries>
        <crgID>0</crgID>
        <crossoverTrial>false</crossoverTrial>
        <designAddedInfo></designAddedInfo>
        <designProse>Design: parallel</designProse>
        <detectionBiasJudgement>Double blind: no further details.</detectionBiasJudgement>
        <detectionBiasRisk>Unclear Risk</detectionBiasRisk>
        <dobj>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>22</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>73</group1Total>
            <group2Events>29</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>85</group2Total>
            <outcomeName>Leaving study early</outcomeName>
            <subgroupName>long-term</subgroupName>
        </dobj>
        <factorialTrial>false</factorialTrial>
        <mainAuthor>Adler</mainAuthor>
        <meerKatCountry>USA</meerKatCountry>
        <nrControl>0</nrControl>
        <nrIntervention>0</nrIntervention>
        <nrOfParticipants>0</nrOfParticipants>
        <otherBiasJudgement>No significant differences between groups' baseline characteristics. Small sample size.</otherBiasJudgement>
        <otherBiasRisk>Unclear Risk</otherBiasRisk>
        <otherDesign>false</otherDesign>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>68</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>73</group1Total>
            <group2Events>82</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>85</group2Total>
            <outcomeName>Tardive dyskinesia: 1. Not improved to a clinically important extent</outcomeName>
            <subgroupName>long-term</subgroupName>
        </outcomeList>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>56</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>73</group1Total>
            <group2Events>68</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>85</group2Total>
            <outcomeName>Tardive dyskinesia: 2. Not any improvement</outcomeName>
            <subgroupName>long-term</subgroupName>
        </outcomeList>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>22</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>73</group1Total>
            <group2Events>29</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>85</group2Total>
            <outcomeName>Leaving study early</outcomeName>
            <subgroupName>long-term</subgroupName>
        </outcomeList>
        <paralellTrial>true</paralellTrial>
        <performanceBiasJudgement>Double blind: no further details.</performanceBiasJudgement>
        <performanceBiasRisk>Unclear Risk</performanceBiasRisk>
        <references>JOURNAL_ARTICLE</references>
        <references>YES</references>
        <references>Adler LA, Rotrosen J, Edson R, Lavori P, Lohr J, Hitzemann R, et al</references>
        <references>Vitamin E treatment for tardive dyskinesia</references>
        <references>Archives of General Psychiatry</references>
        <references>1999</references>
        <references>56</references>
        <references></references>
        <references>836-41</references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references>JOURNAL_ARTICLE</references>
        <references>NO</references>
        <references>Adler LA, Rotrosen J, Lavori P, Edson R</references>
        <references>Vitamin E treatment of TD: development of a VA cooperative study</references>
        <references>Biological Psychiatry</references>
        <references>1994</references>
        <references>35</references>
        <references></references>
        <references>730-1</references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references>JOURNAL_ARTICLE</references>
        <references>NO</references>
        <references>Bridler R</references>
        <references>Vitamin E is ineffective in treatment of late dyskinesias</references>
        <references>Praxis</references>
        <references>2001</references>
        <references>90</references>
        <references>18</references>
        <references>809-10</references>
        <references>Vitamin E unwirksam in der Behandlung von Spatdyskinesien (TD)</references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references>JOURNAL_ARTICLE</references>
        <references>NO</references>
        <references>Caligiuri MP, Lohr JB, Rotrosen J, Adler L, Lavori P, Edson R, et al</references>
        <references>Reliability of an instrumental assessment of tardive dyskinesia: results from VA Cooperative Study #394</references>
        <references>Psychopharmacology</references>
        <references>1997</references>
        <references>132</references>
        <references></references>
        <references>61-6</references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references>JOURNAL_ARTICLE</references>
        <references>NO</references>
        <references>Edson R, Lavori P, Tracy K, Adler LA, Rotrosen J</references>
        <references>Interrater reliability issues in multicentric trials, part II: statistical procedures used in Department of Veterans Affairs Cooperative Study #394</references>
        <references>Psychopharmacology Bulletin</references>
        <references>1997</references>
        <references>33</references>
        <references></references>
        <references>59-67</references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references>JOURNAL_ARTICLE</references>
        <references>NO</references>
        <references>Lohr JB, Lavori P</references>
        <references>Whither vitamin E and tardive dyskinesia?</references>
        <references>Biological Psychiatry</references>
        <references>1998</references>
        <references>43</references>
        <references></references>
        <references>861-2</references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references>JOURNAL_ARTICLE</references>
        <references>NO</references>
        <references>Tracy K, Adler LA, Rotrosen J, Edson R, Lavori P</references>
        <references>Interrater reliability issues in multicentric trials, part I: theoretical concepts and operational procedures used in Department of Veterans Affairs Cooperative Study 394</references>
        <references>Psychopharmacology Bulletin</references>
        <references>1997</references>
        <references>33</references>
        <references></references>
        <references>53-7</references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <reportingBiasJudgement>All expected outcomes have been reported but there is no study protocol to confirm that all planned outcomes were reported.</reportingBiasJudgement>
        <reportingBiasRisk>Unclear Risk</reportingBiasRisk>
        <revManID>STD-Adler-1999</revManID>
        <selectionBiasAllocationConcealmentBiasRisk>Low risk</selectionBiasAllocationConcealmentBiasRisk>
        <selectionBiasAllocationConcealmentJudgement>Allocation with "biased coin" method, stratified by site, age, and baseline TD.</selectionBiasAllocationConcealmentJudgement>
        <selectionBiasRandomSequenceBiasRisk>Low risk</selectionBiasRandomSequenceBiasRisk>
        <selectionBiasRandomSequenceJudgement>Randomisation coordinated centrally.</selectionBiasRandomSequenceJudgement>
        <year>1999</year>
    </trialList>
    <trialList>
        <attritionBiasJudgement>The study results seem to include all participants and there seem to be no dropouts from the study.</attritionBiasJudgement>
        <attritionBiasRisk>Low risk</attritionBiasRisk>
        <authorYearLetter>Akhtar1993</authorYearLetter>
        <countries>India</countries>
        <crgID>0</crgID>
        <crossoverTrial>false</crossoverTrial>
        <designAddedInfo></designAddedInfo>
        <designProse>Design: parallel group</designProse>
        <detectionBiasJudgement>"Both, the investigators and raters were blind to the nature of therapy · active drug or placebo till the completion of analysis.</detectionBiasJudgement>
        <detectionBiasRisk>Low risk</detectionBiasRisk>
        <dobj>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>0</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>17</group1Total>
            <group2Events>0</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>15</group2Total>
            <outcomeName>Leaving study early</outcomeName>
            <subgroupName>short-term</subgroupName>
        </dobj>
        <factorialTrial>false</factorialTrial>
        <mainAuthor>Akhtar</mainAuthor>
        <meerKatCountry>India</meerKatCountry>
        <nrControl>0</nrControl>
        <nrIntervention>0</nrIntervention>
        <nrOfParticipants>0</nrOfParticipants>
        <otherBiasJudgement>There was no significant difference in the demographic profile of the two groups. Small sample size.</otherBiasJudgement>
        <otherBiasRisk>Unclear Risk</otherBiasRisk>
        <otherDesign>false</otherDesign>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>0</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>17</group1Total>
            <group2Events>0</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>15</group2Total>
            <outcomeName>Any adverse effect</outcomeName>
            <subgroupName>short-term</subgroupName>
        </outcomeList>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>0</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>17</group1Total>
            <group2Events>0</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>15</group2Total>
            <outcomeName>Discontinuation due to adverse effect</outcomeName>
            <subgroupName>short-term</subgroupName>
        </outcomeList>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>0</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>17</group1Total>
            <group2Events>0</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>15</group2Total>
            <outcomeName>Leaving study early</outcomeName>
            <subgroupName>short-term</subgroupName>
        </outcomeList>
        <paralellTrial>true</paralellTrial>
        <performanceBiasJudgement>"double blind manner to receive either one capsule of 600 mg vitamin E or an identical placebo".</performanceBiasJudgement>
        <performanceBiasRisk>Low risk</performanceBiasRisk>
        <references>JOURNAL_ARTICLE</references>
        <references>YES</references>
        <references>Akhtar S, Jajor TR, Kumar S</references>
        <references>Vitamin E in the treatment of tardive dyskinesia</references>
        <references>Journal of Postgraduate Medicine</references>
        <references>1993</references>
        <references>39</references>
        <references></references>
        <references>124-6</references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <reportingBiasJudgement>All expected outcomes have been reported but there is no study protocol to confirm that all planned outcomes were reported.</reportingBiasJudgement>
        <reportingBiasRisk>Unclear Risk</reportingBiasRisk>
        <revManID>STD-Akhtar-1993</revManID>
        <selectionBiasAllocationConcealmentBiasRisk>Unclear Risk</selectionBiasAllocationConcealmentBiasRisk>
        <selectionBiasAllocationConcealmentJudgement>Allocation concealment not reported.</selectionBiasAllocationConcealmentJudgement>
        <selectionBiasRandomSequenceBiasRisk>Unclear Risk</selectionBiasRandomSequenceBiasRisk>
        <selectionBiasRandomSequenceJudgement>"The patients were then randomly assigned". Details not reported.</selectionBiasRandomSequenceJudgement>
        <year>1993</year>
    </trialList>
    <trialList>
        <attritionBiasJudgement>"One patient who was taking vitamin E stopped treatment after 2 weeks because of diarrhea, leaving five patients taking placebo and six vitamin E".</attritionBiasJudgement>
        <attritionBiasRisk>Low risk</attritionBiasRisk>
        <authorYearLetter>Dabiri1994</authorYearLetter>
        <countries>USA</countries>
        <crgID>0</crgID>
        <crossoverTrial>false</crossoverTrial>
        <designAddedInfo></designAddedInfo>
        <designProse>Design: parallel group</designProse>
        <detectionBiasJudgement>"Each patient was rated blindly by one of us (L.M.D.) before and after treatment using the Abnormal Involuntary Movement Scale (AIMS)". Blinding details not reported.</detectionBiasJudgement>
        <detectionBiasRisk>Unclear Risk</detectionBiasRisk>
        <dobj>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>1</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>7</group1Total>
            <group2Events>0</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>5</group2Total>
            <outcomeName>Leaving study early</outcomeName>
            <subgroupName>medium-term</subgroupName>
        </dobj>
        <factorialTrial>false</factorialTrial>
        <mainAuthor>Dabiri</mainAuthor>
        <meerKatCountry>USA</meerKatCountry>
        <nrControl>0</nrControl>
        <nrIntervention>0</nrIntervention>
        <nrOfParticipants>0</nrOfParticipants>
        <otherBiasJudgement>No statistically significant differences in AIMS baseline scores between groups. Very small sample size.</otherBiasJudgement>
        <otherBiasRisk>Unclear Risk</otherBiasRisk>
        <otherDesign>false</otherDesign>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>1</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>7</group1Total>
            <group2Events>0</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>5</group2Total>
            <outcomeName>Any adverse effect</outcomeName>
            <subgroupName>medium-term</subgroupName>
        </outcomeList>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>1</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>7</group1Total>
            <group2Events>0</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>5</group2Total>
            <outcomeName>Leaving study early</outcomeName>
            <subgroupName>medium-term</subgroupName>
        </outcomeList>
        <paralellTrial>true</paralellTrial>
        <performanceBiasJudgement>"double-blind study", details not reported.</performanceBiasJudgement>
        <performanceBiasRisk>Unclear Risk</performanceBiasRisk>
        <references>JOURNAL_ARTICLE</references>
        <references>YES</references>
        <references>Dabiri LM, Pasta D, Darby JK, Mosbacher D</references>
        <references>Effectiveness of vitamin E for treatment of long-term tardive dyskinesia</references>
        <references>American Journal of Psychiatry</references>
        <references>1994</references>
        <references>151</references>
        <references></references>
        <references>925-6</references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <reportingBiasJudgement>All expected outcomes have been reported but there is no study protocol to confirm that all planned outcomes were reported.</reportingBiasJudgement>
        <reportingBiasRisk>Unclear Risk</reportingBiasRisk>
        <revManID>STD-Dabiri-1994</revManID>
        <selectionBiasAllocationConcealmentBiasRisk>Low risk</selectionBiasAllocationConcealmentBiasRisk>
        <selectionBiasAllocationConcealmentJudgement>"patients were randomly divided into treatment and placebo groups by a non-clinical staff member".</selectionBiasAllocationConcealmentJudgement>
        <selectionBiasRandomSequenceBiasRisk>Unclear Risk</selectionBiasRandomSequenceBiasRisk>
        <selectionBiasRandomSequenceJudgement>'random allocation', no further details.</selectionBiasRandomSequenceJudgement>
        <year>1994</year>
    </trialList>
    <trialList>
        <attritionBiasJudgement>The study results seem to include all participants and there seem to be no dropouts from the study.</attritionBiasJudgement>
        <attritionBiasRisk>Low risk</attritionBiasRisk>
        <authorYearLetter>Dorevitch1997a</authorYearLetter>
        <countries>Israel</countries>
        <crgID>0</crgID>
        <crossoverTrial>true</crossoverTrial>
        <designAddedInfo></designAddedInfo>
        <designProse>Design: crossover</designProse>
        <detectionBiasJudgement>"double-blind". Blinding details not reported.</detectionBiasJudgement>
        <detectionBiasRisk>Unclear Risk</detectionBiasRisk>
        <dobj>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>0</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>5</group1Total>
            <group2Events>0</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>5</group2Total>
            <outcomeName>Leaving study early</outcomeName>
            <subgroupName>medium-term</subgroupName>
        </dobj>
        <factorialTrial>false</factorialTrial>
        <mainAuthor>Dorevitch</mainAuthor>
        <meerKatCountry>Israel</meerKatCountry>
        <nrControl>0</nrControl>
        <nrIntervention>0</nrIntervention>
        <nrOfParticipants>0</nrOfParticipants>
        <otherBiasJudgement>Baseline characteristics not reported. Very small sample size.</otherBiasJudgement>
        <otherBiasRisk>Unclear Risk</otherBiasRisk>
        <otherDesign>false</otherDesign>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>0</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>5</group1Total>
            <group2Events>0</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>5</group2Total>
            <outcomeName>Any adverse effect</outcomeName>
            <subgroupName>medium-term</subgroupName>
        </outcomeList>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>0</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>5</group1Total>
            <group2Events>0</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>5</group2Total>
            <outcomeName>Discontinuation due to adverse effect</outcomeName>
            <subgroupName>medium-term</subgroupName>
        </outcomeList>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>0</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>5</group1Total>
            <group2Events>0</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>5</group2Total>
            <outcomeName>Leaving study early</outcomeName>
            <subgroupName>medium-term</subgroupName>
        </outcomeList>
        <paralellTrial>false</paralellTrial>
        <performanceBiasJudgement>"double-blind". Blinding details not reported.</performanceBiasJudgement>
        <performanceBiasRisk>Unclear Risk</performanceBiasRisk>
        <references>JOURNAL_ARTICLE</references>
        <references>YES</references>
        <references>Dorevitch A, Lerner V, Shalfman M, Kalian M</references>
        <references>Lack of effect of vitamin E on serum creatine phosphokinase in patients with long-term tardive dyskinesia</references>
        <references>International Clinical Psychopharmacology</references>
        <references>1997</references>
        <references>12</references>
        <references></references>
        <references>171-3</references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <reportingBiasJudgement>TD symptoms (AIMS) were assessed but not reported.</reportingBiasJudgement>
        <reportingBiasRisk>High risk</reportingBiasRisk>
        <revManID>STD-Dorevitch-1997a</revManID>
        <selectionBiasAllocationConcealmentBiasRisk>Unclear Risk</selectionBiasAllocationConcealmentBiasRisk>
        <selectionBiasAllocationConcealmentJudgement>Allocation concealment not reported.</selectionBiasAllocationConcealmentJudgement>
        <selectionBiasRandomSequenceBiasRisk>Unclear Risk</selectionBiasRandomSequenceBiasRisk>
        <selectionBiasRandomSequenceJudgement>"randomized". Details not reported.</selectionBiasRandomSequenceJudgement>
        <year>1997</year>
    </trialList>
    <trialList>
        <attritionBiasJudgement>"Two patients did not complete the study. Both patients were from the placebo phase of the placebo-vitamin E sequence group. One died while choking on food and the second as the result of a traffic accident".</attritionBiasJudgement>
        <attritionBiasRisk>Unclear Risk</attritionBiasRisk>
        <authorYearLetter>Dorevitch1997b</authorYearLetter>
        <countries>Israel</countries>
        <crgID>0</crgID>
        <crossoverTrial>true</crossoverTrial>
        <designAddedInfo></designAddedInfo>
        <designProse>Design: cross-over</designProse>
        <detectionBiasJudgement>"Two senior psychiatrists served as blinded raters".</detectionBiasJudgement>
        <detectionBiasRisk>Low risk</detectionBiasRisk>
        <dobj>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>0</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>18</group1Total>
            <group2Events>2</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>22</group2Total>
            <outcomeName>Leaving study early</outcomeName>
            <subgroupName>medium-term</subgroupName>
        </dobj>
        <factorialTrial>false</factorialTrial>
        <mainAuthor>Dorevitch</mainAuthor>
        <meerKatCountry>Israel</meerKatCountry>
        <nrControl>0</nrControl>
        <nrIntervention>0</nrIntervention>
        <nrOfParticipants>0</nrOfParticipants>
        <otherBiasJudgement>Baseline characteristics not reported.Small sample size.</otherBiasJudgement>
        <otherBiasRisk>Unclear Risk</otherBiasRisk>
        <otherDesign>false</otherDesign>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>0</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>18</group1Total>
            <group2Events>0</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>22</group2Total>
            <outcomeName>Any adverse effect</outcomeName>
            <subgroupName>medium-term</subgroupName>
        </outcomeList>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>0</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>18</group1Total>
            <group2Events>0</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>22</group2Total>
            <outcomeName>Discontinuation due to adverse effect</outcomeName>
            <subgroupName>medium-term</subgroupName>
        </outcomeList>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>0</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>18</group1Total>
            <group2Events>2</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>22</group2Total>
            <outcomeName>Leaving study early</outcomeName>
            <subgroupName>medium-term</subgroupName>
        </outcomeList>
        <paralellTrial>false</paralellTrial>
        <performanceBiasJudgement>"double-blind," Blnding details were not reported.</performanceBiasJudgement>
        <performanceBiasRisk>Unclear Risk</performanceBiasRisk>
        <references>JOURNAL_ARTICLE</references>
        <references>NO</references>
        <references>Dorevitch A, Kalian M, Shlafman M, Lerner V</references>
        <references>Treatment of long-term tardive dyskinesia with vitamin E</references>
        <references>Biological Psychiatry</references>
        <references>1997</references>
        <references>41</references>
        <references></references>
        <references>114-6</references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <reportingBiasJudgement>“Addition of vitamin E or placebo did not adversely affect patient mental status as measured by brief psychiatric rating scale (BPRS).“ BPRS data not fully reported.</reportingBiasJudgement>
        <reportingBiasRisk>High risk</reportingBiasRisk>
        <revManID>STD-Dorevitch-1997b</revManID>
        <selectionBiasAllocationConcealmentBiasRisk>Unclear Risk</selectionBiasAllocationConcealmentBiasRisk>
        <selectionBiasAllocationConcealmentJudgement>Allocation concealment not reported.</selectionBiasAllocationConcealmentJudgement>
        <selectionBiasRandomSequenceBiasRisk>Unclear Risk</selectionBiasRandomSequenceBiasRisk>
        <selectionBiasRandomSequenceJudgement>"Randomised" - no further details.</selectionBiasRandomSequenceJudgement>
        <year>1997</year>
    </trialList>
    <trialList>
        <attritionBiasJudgement>Not ITT analysis: "Eighteen patients who demonstrated high blood levels of vitamin E were included in the data analysis", 3 patients were excluded from the analysis.</attritionBiasJudgement>
        <attritionBiasRisk>High risk</attritionBiasRisk>
        <authorYearLetter>Egan1992</authorYearLetter>
        <countries>USA</countries>
        <crgID>0</crgID>
        <crossoverTrial>true</crossoverTrial>
        <designAddedInfo></designAddedInfo>
        <designProse>Design: cross-over</designProse>
        <detectionBiasJudgement>"All raters were blind to treatment with either placebo or vitamin E. ".</detectionBiasJudgement>
        <detectionBiasRisk>Low risk</detectionBiasRisk>
        <dobj>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>1</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>10</group1Total>
            <group2Events>2</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>11</group2Total>
            <outcomeName>Leaving study early</outcomeName>
            <subgroupName>medium-term</subgroupName>
        </dobj>
        <factorialTrial>false</factorialTrial>
        <mainAuthor>Egan</mainAuthor>
        <meerKatCountry>USA</meerKatCountry>
        <nrControl>0</nrControl>
        <nrIntervention>0</nrIntervention>
        <nrOfParticipants>0</nrOfParticipants>
        <otherBiasJudgement>Baseline characteristics not reported. Very small sample size.</otherBiasJudgement>
        <otherBiasRisk>Unclear Risk</otherBiasRisk>
        <otherDesign>false</otherDesign>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>0</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>10</group1Total>
            <group2Events>0</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>11</group2Total>
            <outcomeName>Any adverse effect</outcomeName>
            <subgroupName>medium-term</subgroupName>
        </outcomeList>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>0</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>10</group1Total>
            <group2Events>0</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>11</group2Total>
            <outcomeName>Discontinuation due to adverse effect</outcomeName>
            <subgroupName>medium-term</subgroupName>
        </outcomeList>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>1</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>10</group1Total>
            <group2Events>2</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>11</group2Total>
            <outcomeName>Leaving study early</outcomeName>
            <subgroupName>medium-term</subgroupName>
        </outcomeList>
        <paralellTrial>false</paralellTrial>
        <performanceBiasJudgement>"double-blind," Details not reported.</performanceBiasJudgement>
        <performanceBiasRisk>Unclear Risk</performanceBiasRisk>
        <references>JOURNAL_ARTICLE</references>
        <references>YES</references>
        <references>Egan MF, Hyde TM, Albers GW, Elkashef A, Alexander RC, Reeve A, et al</references>
        <references>Treatment of tardive dyskinesia with vitamin E</references>
        <references>American Journal of Psychiatry</references>
        <references>1992</references>
        <references>149</references>
        <references></references>
        <references>773-7</references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <reportingBiasJudgement>Data for mental state (PSAS and NSAS) not reported.</reportingBiasJudgement>
        <reportingBiasRisk>High risk</reportingBiasRisk>
        <revManID>STD-Egan-1992</revManID>
        <selectionBiasAllocationConcealmentBiasRisk>Unclear Risk</selectionBiasAllocationConcealmentBiasRisk>
        <selectionBiasAllocationConcealmentJudgement>Allocation concealment not reported.</selectionBiasAllocationConcealmentJudgement>
        <selectionBiasRandomSequenceBiasRisk>Unclear Risk</selectionBiasRandomSequenceBiasRisk>
        <selectionBiasRandomSequenceJudgement>"Patients were assigned randomly" Details not reported.</selectionBiasRandomSequenceJudgement>
        <year>1992</year>
    </trialList>
    <trialList>
        <attritionBiasJudgement>2/5 subjects in the placebo group while none in the vitamin E group dropped out: "Two patients did not complete the study, one because of noncompliance and the other experienced substantial side effects (nausea) while taking placebo".</attritionBiasJudgement>
        <attritionBiasRisk>High risk</attritionBiasRisk>
        <authorYearLetter>Elkashef1990</authorYearLetter>
        <countries>USA</countries>
        <crgID>0</crgID>
        <crossoverTrial>true</crossoverTrial>
        <designAddedInfo></designAddedInfo>
        <designProse>Design: cross-over</designProse>
        <detectionBiasJudgement>"The subjects were evaluated biweekly by a blind trained rater using the AIMS and the Brief Psychiatric Rating Scale (BPRS)" Details of blinding not reported.</detectionBiasJudgement>
        <detectionBiasRisk>Unclear Risk</detectionBiasRisk>
        <dobj>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>0</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>5</group1Total>
            <group2Events>2</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>5</group2Total>
            <outcomeName>Leaving study early</outcomeName>
            <subgroupName>short-term</subgroupName>
        </dobj>
        <factorialTrial>false</factorialTrial>
        <mainAuthor>Elkashef</mainAuthor>
        <meerKatCountry>USA</meerKatCountry>
        <nrControl>0</nrControl>
        <nrIntervention>0</nrIntervention>
        <nrOfParticipants>0</nrOfParticipants>
        <otherBiasJudgement>The baseline severity of tardive dyskinesia was closely matched in the two groups. Very small sample size.</otherBiasJudgement>
        <otherBiasRisk>Unclear Risk</otherBiasRisk>
        <otherDesign>false</otherDesign>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>5</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>5</group1Total>
            <group2Events>5</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>5</group2Total>
            <outcomeName>Tardive dyskinesia: 1. Not improved to a clinically important extent</outcomeName>
            <subgroupName>short-term</subgroupName>
        </outcomeList>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>0</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>5</group1Total>
            <group2Events>3</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>5</group2Total>
            <outcomeName>Tardive dyskinesia: 2. Not any improvement</outcomeName>
            <subgroupName>short-term</subgroupName>
        </outcomeList>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>0</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>5</group1Total>
            <group2Events>0</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>3</group2Total>
            <outcomeName>Tardive dyskinesia: 4. Deterioration of symptoms</outcomeName>
            <subgroupName>short-term</subgroupName>
        </outcomeList>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>0</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>5</group1Total>
            <group2Events>1</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>5</group2Total>
            <outcomeName>Any adverse effect</outcomeName>
            <subgroupName>short-term</subgroupName>
        </outcomeList>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>0</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>5</group1Total>
            <group2Events>2</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>5</group2Total>
            <outcomeName>Leaving study early</outcomeName>
            <subgroupName>short-term</subgroupName>
        </outcomeList>
        <paralellTrial>false</paralellTrial>
        <performanceBiasJudgement>Double blind: no further details.</performanceBiasJudgement>
        <performanceBiasRisk>Unclear Risk</performanceBiasRisk>
        <references>JOURNAL_ARTICLE</references>
        <references>YES</references>
        <references>Elkashef AM, Ruskin PE, Bacher N, Barret D</references>
        <references>Vitamin E in the treatment of tardive dyskinesia</references>
        <references>American Journal of Psychiatry</references>
        <references>1990</references>
        <references>147</references>
        <references></references>
        <references>505-6</references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <reportingBiasJudgement>AIMS data partially reported and BPRS evaluated but not reported.</reportingBiasJudgement>
        <reportingBiasRisk>High risk</reportingBiasRisk>
        <revManID>STD-Elkashef-1990</revManID>
        <selectionBiasAllocationConcealmentBiasRisk>Unclear Risk</selectionBiasAllocationConcealmentBiasRisk>
        <selectionBiasAllocationConcealmentJudgement>Allocation concealment not reported.</selectionBiasAllocationConcealmentJudgement>
        <selectionBiasRandomSequenceBiasRisk>Unclear Risk</selectionBiasRandomSequenceBiasRisk>
        <selectionBiasRandomSequenceJudgement>"The subjects were then assigned in a random, double-blind manner...", no further details.</selectionBiasRandomSequenceJudgement>
        <year>1990</year>
    </trialList>
    <trialList>
        <attritionBiasJudgement>Twelve subjects completed the trial. One patient died of unrelated medical illness, one contracted bacillary dysentery and was dropped from the trial, and one had poor compliance and refused to continue medication. It was not reported which groups these participants were allocated to.</attritionBiasJudgement>
        <attritionBiasRisk>High risk</attritionBiasRisk>
        <authorYearLetter>Lam1994</authorYearLetter>
        <countries>Hong Kong</countries>
        <crgID>0</crgID>
        <crossoverTrial>true</crossoverTrial>
        <designAddedInfo></designAddedInfo>
        <designProse>Design: cross-over</designProse>
        <detectionBiasJudgement>"Subjects were evaluated weekly with the AIMS...and Brief Psychiatric Rating Scale..., respectively, by two independent blind raters at the initial stabilization period,and the last 2 weeks of each test period".</detectionBiasJudgement>
        <detectionBiasRisk>Low risk</detectionBiasRisk>
        <dobj>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>3</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>8</group1Total>
            <group2Events>1</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>8</group2Total>
            <outcomeName>Leaving study early</outcomeName>
            <subgroupName>medium-term</subgroupName>
        </dobj>
        <factorialTrial>false</factorialTrial>
        <mainAuthor>Lam</mainAuthor>
        <meerKatCountry>Hong Kong</meerKatCountry>
        <nrControl>0</nrControl>
        <nrIntervention>0</nrIntervention>
        <nrOfParticipants>0</nrOfParticipants>
        <otherBiasJudgement>Baseline characteristics not reported. Very small sample size.</otherBiasJudgement>
        <otherBiasRisk>Unclear Risk</otherBiasRisk>
        <otherDesign>false</otherDesign>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>8</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>8</group1Total>
            <group2Events>8</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>8</group2Total>
            <outcomeName>Tardive dyskinesia: 1. Not improved to a clinically important extent</outcomeName>
            <subgroupName>medium-term</subgroupName>
        </outcomeList>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>0</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>8</group1Total>
            <group2Events>0</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>8</group2Total>
            <outcomeName>Tardive dyskinesia: 2. Not any improvement</outcomeName>
            <subgroupName>medium-term</subgroupName>
        </outcomeList>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>0</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>5</group1Total>
            <group2Events>0</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>7</group2Total>
            <outcomeName>Tardive dyskinesia: 4. Deterioration of symptoms</outcomeName>
            <subgroupName>medium-term</subgroupName>
        </outcomeList>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>3</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>8</group1Total>
            <group2Events>1</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>8</group2Total>
            <outcomeName>Leaving study early</outcomeName>
            <subgroupName>medium-term</subgroupName>
        </outcomeList>
        <paralellTrial>false</paralellTrial>
        <performanceBiasJudgement>"double-blind". Details not reported.</performanceBiasJudgement>
        <performanceBiasRisk>Unclear Risk</performanceBiasRisk>
        <references>JOURNAL_ARTICLE</references>
        <references>YES</references>
        <references>Lam LCW, Chiu HFK, Hung SF</references>
        <references>Vitamin E in the treatment of tardive dyskinesia: a replication study</references>
        <references>Journal of Nervous and Mental Diseases</references>
        <references>1994</references>
        <references>182</references>
        <references></references>
        <references>113-4</references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <reportingBiasJudgement>TD symptoms data not reported as mean (SD); BPRS data not reported per period. Adverse effects not reported per group.</reportingBiasJudgement>
        <reportingBiasRisk>High risk</reportingBiasRisk>
        <revManID>STD-Lam-1994</revManID>
        <selectionBiasAllocationConcealmentBiasRisk>Unclear Risk</selectionBiasAllocationConcealmentBiasRisk>
        <selectionBiasAllocationConcealmentJudgement>Allocation concealment not reported.</selectionBiasAllocationConcealmentJudgement>
        <selectionBiasRandomSequenceBiasRisk>Unclear Risk</selectionBiasRandomSequenceBiasRisk>
        <selectionBiasRandomSequenceJudgement>"Subjects were then selected randomly". No further details.</selectionBiasRandomSequenceJudgement>
        <year>1994</year>
    </trialList>
    <trialList>
        <attritionBiasJudgement>Dropout rate of 36% (20 of 55 patients) but not reported per study group "2 developed manic symptoms necessitating medical changes, and 18 were non-compliant with either the vitamin E or the psychotropic medication. These 20 patients, who did not differ significantly from the remaining 35 patients in terms of age, gender, or diagnosis, were dropped from the study".</attritionBiasJudgement>
        <attritionBiasRisk>High risk</attritionBiasRisk>
        <authorYearLetter>Lohr1996</authorYearLetter>
        <countries>USA</countries>
        <crgID>0</crgID>
        <crossoverTrial>false</crossoverTrial>
        <designAddedInfo></designAddedInfo>
        <designProse>Design: parallel</designProse>
        <detectionBiasJudgement>Insufficient information to make a judgement.</detectionBiasJudgement>
        <detectionBiasRisk>Unclear Risk</detectionBiasRisk>
        <dobj>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>10</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>27</group1Total>
            <group2Events>10</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>28</group2Total>
            <outcomeName>Leaving study early</outcomeName>
            <subgroupName>medium-term</subgroupName>
        </dobj>
        <factorialTrial>false</factorialTrial>
        <mainAuthor>Lohr</mainAuthor>
        <meerKatCountry>USA</meerKatCountry>
        <nrControl>0</nrControl>
        <nrIntervention>0</nrIntervention>
        <nrOfParticipants>0</nrOfParticipants>
        <otherBiasJudgement>There were no significant differences in baseline characteristics between the two study groups. Small sample size.</otherBiasJudgement>
        <otherBiasRisk>Unclear Risk</otherBiasRisk>
        <otherDesign>false</otherDesign>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>22</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>27</group1Total>
            <group2Events>26</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>28</group2Total>
            <outcomeName>Tardive dyskinesia: 2. Not any improvement</outcomeName>
            <subgroupName>medium-term</subgroupName>
        </outcomeList>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>10</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>27</group1Total>
            <group2Events>10</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>28</group2Total>
            <outcomeName>Leaving study early</outcomeName>
            <subgroupName>medium-term</subgroupName>
        </outcomeList>
        <paralellTrial>true</paralellTrial>
        <performanceBiasJudgement>"Patients were randomly assigned to receive either active vitamin E or sesame oil placebo gel caps, which were indistinguishable from the active gel caps."</performanceBiasJudgement>
        <performanceBiasRisk>Low risk</performanceBiasRisk>
        <references>JOURNAL_ARTICLE</references>
        <references>YES</references>
        <references>Lohr JB, Caliguiri M</references>
        <references>A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia</references>
        <references>Journal of Clinical Psychiatry</references>
        <references>1996</references>
        <references>57</references>
        <references></references>
        <references>167-73</references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <reportingBiasJudgement>Adverse Effects: extrapyramidal side effects (Parkinsonism) data not reported.</reportingBiasJudgement>
        <reportingBiasRisk>High risk</reportingBiasRisk>
        <revManID>STD-Lohr-1996</revManID>
        <selectionBiasAllocationConcealmentBiasRisk>Unclear Risk</selectionBiasAllocationConcealmentBiasRisk>
        <selectionBiasAllocationConcealmentJudgement>Allocation concealment details not reported.</selectionBiasAllocationConcealmentJudgement>
        <selectionBiasRandomSequenceBiasRisk>Unclear Risk</selectionBiasRandomSequenceBiasRisk>
        <selectionBiasRandomSequenceJudgement>"Patients were randomly assigned to receive either active vitamin E or sesame oil placebo gelcaps."</selectionBiasRandomSequenceJudgement>
        <year>1996</year>
    </trialList>
    <trialList>
        <attritionBiasJudgement>40% drop-out (12/20 subjects completed the study): 6/11 subjects in the intervention and 2/9 subjects in the control group did not complete the trial. By the fourth month, there were 12 patients left in the trial, five in the treatment group and seven in the control group. Patients excluded at this stage included those whose dose of antipsychotic medication was changed.</attritionBiasJudgement>
        <attritionBiasRisk>High risk</attritionBiasRisk>
        <authorYearLetter>Sajjad1998</authorYearLetter>
        <countries>UK</countries>
        <crgID>0</crgID>
        <crossoverTrial>false</crossoverTrial>
        <designAddedInfo></designAddedInfo>
        <designProse>Design: parallel</designProse>
        <detectionBiasJudgement>Rater initially blind. However, after one month, the rater performed statistical tests and hence blindness was not maintained.</detectionBiasJudgement>
        <detectionBiasRisk>High risk</detectionBiasRisk>
        <dobj>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>6</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>11</group1Total>
            <group2Events>2</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>9</group2Total>
            <outcomeName>Leaving study early</outcomeName>
            <subgroupName>long-term</subgroupName>
        </dobj>
        <factorialTrial>false</factorialTrial>
        <mainAuthor>Sajjad</mainAuthor>
        <meerKatCountry>UK</meerKatCountry>
        <nrControl>0</nrControl>
        <nrIntervention>0</nrIntervention>
        <nrOfParticipants>0</nrOfParticipants>
        <otherBiasJudgement>Mean AIMS scores and age were similar between groups at baseline. Very small sample size.</otherBiasJudgement>
        <otherBiasRisk>Unclear Risk</otherBiasRisk>
        <otherDesign>false</otherDesign>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>8</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>11</group1Total>
            <group2Events>9</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>9</group2Total>
            <outcomeName>Tardive dyskinesia: 1. Not improved to a clinically important extent</outcomeName>
            <subgroupName>long-term</subgroupName>
        </outcomeList>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>7</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>11</group1Total>
            <group2Events>6</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>9</group2Total>
            <outcomeName>Tardive dyskinesia: 2. Not any improvement</outcomeName>
            <subgroupName>long-term</subgroupName>
        </outcomeList>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>1</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>10</group1Total>
            <group2Events>4</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>8</group2Total>
            <outcomeName>Tardive dyskinesia: 4. Deterioration of symptoms</outcomeName>
            <subgroupName>long-term</subgroupName>
        </outcomeList>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>1</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>11</group1Total>
            <group2Events>0</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>9</group2Total>
            <outcomeName>Any adverse effect</outcomeName>
            <subgroupName>long-term</subgroupName>
        </outcomeList>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>1</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>11</group1Total>
            <group2Events>0</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>9</group2Total>
            <outcomeName>Discontinuation due to adverse effect</outcomeName>
            <subgroupName>long-term</subgroupName>
        </outcomeList>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>6</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>11</group1Total>
            <group2Events>2</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>9</group2Total>
            <outcomeName>Leaving study early</outcomeName>
            <subgroupName>long-term</subgroupName>
        </outcomeList>
        <paralellTrial>true</paralellTrial>
        <performanceBiasJudgement>As an active group was compared to treatment as usual, the study could not be double blinded.The only person blinded seems to have been the doctor "...the dose increased by another doctor not involved in the ratings and who, therefore, was blind as to whether or not the patient was receiving a-tocopherol for the first month of the trial".</performanceBiasJudgement>
        <performanceBiasRisk>High risk</performanceBiasRisk>
        <references>JOURNAL_ARTICLE</references>
        <references>YES</references>
        <references>Sajjad S</references>
        <references>Vitamin E in the treatment of tardive dyskinesia: a preliminary study over seven months at different doses</references>
        <references>International Clinical Psychopharmacology</references>
        <references>1998</references>
        <references>13</references>
        <references>4</references>
        <references>147-55</references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <reportingBiasJudgement>All expected outcomes have been reported but there is no study protocol to confirm that all planned outcomes were reported.</reportingBiasJudgement>
        <reportingBiasRisk>Unclear Risk</reportingBiasRisk>
        <revManID>STD-Sajjad-1998</revManID>
        <selectionBiasAllocationConcealmentBiasRisk>Unclear Risk</selectionBiasAllocationConcealmentBiasRisk>
        <selectionBiasAllocationConcealmentJudgement>Allocation concealment not reported.</selectionBiasAllocationConcealmentJudgement>
        <selectionBiasRandomSequenceBiasRisk>Low risk</selectionBiasRandomSequenceBiasRisk>
        <selectionBiasRandomSequenceJudgement>"...the patients were randomly divided into two groups using... a computer statistic programme."</selectionBiasRandomSequenceJudgement>
        <year>1998</year>
    </trialList>
    <trialList>
        <attritionBiasJudgement>13 patients initially randomised to vitamin E: two left before the end of the study (1 died and the other withdrew); 10 patients initially randomised to placebo: two left before the end of the study (1 died and the other had his treatment modified).</attritionBiasJudgement>
        <attritionBiasRisk>Low risk</attritionBiasRisk>
        <authorYearLetter>Schmidt1991</authorYearLetter>
        <countries>Switzerland</countries>
        <crgID>0</crgID>
        <crossoverTrial>true</crossoverTrial>
        <designAddedInfo></designAddedInfo>
        <designProse>Design: crossover</designProse>
        <detectionBiasJudgement>Details not reported.</detectionBiasJudgement>
        <detectionBiasRisk>Unclear Risk</detectionBiasRisk>
        <dobj>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>2</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>13</group1Total>
            <group2Events>2</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>10</group2Total>
            <outcomeName>Leaving study early</outcomeName>
            <subgroupName>short-term</subgroupName>
        </dobj>
        <factorialTrial>false</factorialTrial>
        <mainAuthor>Schmidt</mainAuthor>
        <meerKatCountry>Switzerland</meerKatCountry>
        <nrControl>0</nrControl>
        <nrIntervention>0</nrIntervention>
        <nrOfParticipants>0</nrOfParticipants>
        <otherBiasJudgement>Baseline characteristics similar between study groups. Very small sample size; cross-over design.</otherBiasJudgement>
        <otherBiasRisk>Unclear Risk</otherBiasRisk>
        <otherDesign>false</otherDesign>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>12</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>13</group1Total>
            <group2Events>10</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>10</group2Total>
            <outcomeName>Tardive dyskinesia: 1. Not improved to a clinically important extent</outcomeName>
            <subgroupName>short-term</subgroupName>
        </outcomeList>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>3</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>13</group1Total>
            <group2Events>3</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>10</group2Total>
            <outcomeName>Tardive dyskinesia: 2. Not any improvement</outcomeName>
            <subgroupName>short-term</subgroupName>
        </outcomeList>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>1</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>11</group1Total>
            <group2Events>1</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>8</group2Total>
            <outcomeName>Tardive dyskinesia: 4. Deterioration of symptoms</outcomeName>
            <subgroupName>short-term</subgroupName>
        </outcomeList>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>1</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>13</group1Total>
            <group2Events>1</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>10</group2Total>
            <outcomeName>Any adverse effect</outcomeName>
            <subgroupName>short-term</subgroupName>
        </outcomeList>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>2</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>13</group1Total>
            <group2Events>2</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>10</group2Total>
            <outcomeName>Leaving study early</outcomeName>
            <subgroupName>short-term</subgroupName>
        </outcomeList>
        <paralellTrial>false</paralellTrial>
        <performanceBiasJudgement>"double-blind". Details not reported.</performanceBiasJudgement>
        <performanceBiasRisk>Unclear Risk</performanceBiasRisk>
        <references>JOURNAL_ARTICLE</references>
        <references>YES</references>
        <references>Schmidt M, Meister P, Baumann P</references>
        <references>Treatment of tardive dyskinesias with vitamin E</references>
        <references>European Psychiatry</references>
        <references>1991</references>
        <references>6</references>
        <references></references>
        <references>201-7</references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <reportingBiasJudgement>All expected outcomes have been reported but there is no study protocol to confirm that all planned outcomes were reported.</reportingBiasJudgement>
        <reportingBiasRisk>Unclear Risk</reportingBiasRisk>
        <revManID>STD-Schmidt-1991</revManID>
        <selectionBiasAllocationConcealmentBiasRisk>Unclear Risk</selectionBiasAllocationConcealmentBiasRisk>
        <selectionBiasAllocationConcealmentJudgement>Allocation concealment not reported.</selectionBiasAllocationConcealmentJudgement>
        <selectionBiasRandomSequenceBiasRisk>Unclear Risk</selectionBiasRandomSequenceBiasRisk>
        <selectionBiasRandomSequenceJudgement>"randomized pattern", no further details.</selectionBiasRandomSequenceJudgement>
        <year>1991</year>
    </trialList>
    <trialList>
        <attritionBiasJudgement>"Forty-one inpatients with TD completed a double- blind, placebo-controlled, parallel-group study of vitamin E. Twenty- two of the patients were randomly assigned to receive a fixed dose of 1200 IU/d vitamin E, and 19 were assigned to a placebo". "Eligible patients were randomly assigned to receive either capsulized vitamin E (n=22) or identically capsulized placebo (n=19)". All randomised subjects seem to have completed the study.</attritionBiasJudgement>
        <attritionBiasRisk>Low risk</attritionBiasRisk>
        <authorYearLetter>Zhang2004</authorYearLetter>
        <countries>China</countries>
        <crgID>0</crgID>
        <crossoverTrial>false</crossoverTrial>
        <designAddedInfo></designAddedInfo>
        <designProse>Design: parallel</designProse>
        <detectionBiasJudgement>"TD was evaluated in all patients using the Abnormal Involuntary Movement Scale (AIMS) at baseline, 6 and 12 weeks of treatment by the same trained investigator (DCC) who was blind to the patient's medication status. The patient's psychopathology was rated at baseline and at posttreatment using the Positive and Negative Syndrome Scale (PANSS), 18 which was performed by 2 trained psychiatrists who were blinded scoring the PANSS."</detectionBiasJudgement>
        <detectionBiasRisk>Low risk</detectionBiasRisk>
        <dobj>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>0</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>22</group1Total>
            <group2Events>0</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>19</group2Total>
            <outcomeName>Leaving study early</outcomeName>
            <subgroupName>medium-term</subgroupName>
        </dobj>
        <factorialTrial>false</factorialTrial>
        <mainAuthor>Zhang</mainAuthor>
        <meerKatCountry>China</meerKatCountry>
        <nrControl>0</nrControl>
        <nrIntervention>0</nrIntervention>
        <nrOfParticipants>0</nrOfParticipants>
        <otherBiasJudgement>"No significant differences in demographic data were observed between vitamin E and placebo groups".</otherBiasJudgement>
        <otherBiasRisk>Low risk</otherBiasRisk>
        <otherDesign>false</otherDesign>
        <outcomeList>
            <comparisonName>VITAMIN E versus PLACEBO</comparisonName>
            <group1Events>0</group1Events>
            <group1Intervention>true</group1Intervention>
            <group1Name>vitamin e</group1Name>
            <group1NameProse></group1NameProse>
            <group1Total>22</group1Total>
            <group2Events>0</group2Events>
            <group2Name>placebo</group2Name>
            <group2NameProse></group2NameProse>
            <group2Total>19</group2Total>
            <outcomeName>Leaving study early</outcomeName>
            <subgroupName>medium-term</subgroupName>
        </outcomeList>
        <paralellTrial>true</paralellTrial>
        <performanceBiasJudgement>"either capsulized vitamin E (n=22) or identically capsulized placebo (n=19) using a double-blind fashion."</performanceBiasJudgement>
        <performanceBiasRisk>Low risk</performanceBiasRisk>
        <references>JOURNAL_ARTICLE</references>
        <references>NO</references>
        <references>Zhang XY, Zhou DF, Cao LY, Xu CQ, Chen da C, Wu GY</references>
        <references>The effect of vitamin E treatment on tardive dyskinesia and blood superoxide dismutase: a double-blind placebo-controlled trial</references>
        <references>Journal of Clinical Psychopharmacology</references>
        <references>2004</references>
        <references>24</references>
        <references>1</references>
        <references>83-6</references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <references></references>
        <reportingBiasJudgement>Outcome data was not reported for mental symptoms (PANSS).</reportingBiasJudgement>
        <reportingBiasRisk>High risk</reportingBiasRisk>
        <revManID>STD-Zhang-2004</revManID>
        <selectionBiasAllocationConcealmentBiasRisk>Unclear Risk</selectionBiasAllocationConcealmentBiasRisk>
        <selectionBiasAllocationConcealmentJudgement>Allocation concealment method not reported.</selectionBiasAllocationConcealmentJudgement>
        <selectionBiasRandomSequenceBiasRisk>Unclear Risk</selectionBiasRandomSequenceBiasRisk>
        <selectionBiasRandomSequenceJudgement>"Eligible patients were randomly assigned" no further details.</selectionBiasRandomSequenceJudgement>
        <year>2004</year>
    </trialList>
</database>
